Jazz Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.
CEOBruce C. Cozadd
CEOBruce C. Cozadd
Employees2,800
Employees2,800
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2005
Founded2005
Employees2,800
Employees2,800
JAZZ Key Statistics
Market cap6.57B
Market cap6.57B
Price-Earnings ratio13.88
Price-Earnings ratio13.88
Dividend yield—
Dividend yield—
Average volume1.75M
Average volume1.75M
High today$108.69
High today$108.69
Low today$103.88
Low today$103.88
Open price$103.92
Open price$103.92
Volume1.87M
Volume1.87M
52 Week high$148.06
52 Week high$148.06
52 Week low$95.49
52 Week low$95.49
JAZZ News
Simply Wall St 6d
Earnings Miss: Jazz Pharmaceuticals plc Missed EPS And Analysts Are Revising Their ForecastsThere's been a notable change in appetite for Jazz Pharmaceuticals plc ( ) shares in the week since its first-quarter report, with the stock down 16% to US$98.4...
Analyst ratings
90%
of 20 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.